Molecular Imaging Finds Link Between Obesity and Low Estrogen Levels

A new study presented at SNM’s 58th Annual Meeting could throw open the door to a recently established area of obesity research. Investigators have developed a novel molecular imaging agent that targets estrogenic mechanisms in the brain to find out what effect an enzyme called aromatase has on body mass index (BMI), a measurement of body fat based on height and weight. Aromatase is crucial for the production of estrogen in tissues throughout the body, including the brain.

According to the World Health Organization, worldwide obesity has more than doubled since 1980. As of 2008, an estimated 1.5 billion adults were overweight, and in 2010 nearly 43 million children under the age of five were overweight.

“We used this imaging agent to evaluate the amount of aromatase activity in the brain regions related to eating behaviors, such as the hypothalamus and amygdala, in both overweight and normal weight subjects. We were really surprised to see the highest correlation between aromatase availability and BMI happening in the amygdala, which controls emotional memory,” says Gene-Jack Wang, MD, senior scientist and chair of the medical department at Brookhaven National Laboratory, Upton, N.Y. “Our eating is not only controlled by the hunger centers in the brain. It is also related to memory, and that could have a big impact on a person’s eating behavior. This agent could potentially translate into a number of new studies evaluating estrogen and obesity, food intake and appetite suppression.”

For this study, five healthy overweight subjects and 13 normal-weight subjects of the same age were chosen to undergo positron emission tomography, a molecular imaging technique that provides digital representations of physiological functions of the body. Subjects were injected before imaging with the novel imaging agent (C-11)vorozole, which is composed of a medical isotope bound with an aromatase inhibitor that binds strongly with the active sites of the enzyme in the brain. This allowed investigators to track and quantify the availability of this enzyme to selected areas of the brain associated with hunger and feeding behavior.

A significant correlation was found between high BMI of subjects and decreased uptake of the aromatase inhibitor. Imaging agent uptake was decreased in the hypothalamus (25 percent less), thalamus (27 percent less) and amygdala (30 percent less) in subjects with high BMI. This means that there was less availability of the enzyme in these selected brain regions. There was also a strong inverse correlation between low BMI and imaging agent uptake in the amygdala, meaning BMI was less in subjects showing higher aromatase availability. These findings suggest that there is decreased availability of aromatase in the brains of overweight subjects, conceivably leading to reduced availability of estrogen and potentially less control over appetite and food intake, resulting in weight gain; however, further studies need to be conducted to validate the relationship between estrogen synthesis and high BMI.

Future studies could be introduced to screen eating behaviors of obese subjects in order to further validate the correlation between BMI and estrogen availability in the brain. Based on the current research, theoretically the less estrogen available to the brain, the less control patients may have over their appetite. Studies moderating estrogen and feeding behavior could result in novel drugs for appetite suppression and perhaps even reduction of BMI. This is just the first step toward discovering the mechanisms behind appetite, BMI and estrogen availability.

Read more http://www.sciencedaily.com/releases/2011/06/110606131709.htm

Share

Posted: June 7th, 2011 under Uncategorized.

RSS Medical Imaging News

  • New window of opportunity to prevent cardiovascular, diseases October 23, 2014
    Future prevention and treatment strategies for vascular diseases may lie in the evaluation of early brain imaging tests long before heart attacks or strokes occur, according to a systematic review conducted by a team of cardiologists, neuroscientists, and psychiatrists.
  • Real-time tracking system developed to monitor dangerous bacteria inside body October 22, 2014
    Combining a PET scanner with a new chemical tracer that selectively tags specific types of bacteria, researchers working with mice report they have devised a way to detect and monitor in real time infections with dangerous Gram-negative bacteria. These increasingly drug-resistant bacteria are responsible for a range of diseases, including fatal pneumonias an […]
  • New treatment resolves hazardous airway complication in child with heart disease October 22, 2014
    In children with a heart condition, lymph can ooze into airways and dry into a rubbery, potentially life-threatening cast. A new, noninvasive treatment cleared this blockage in a 6-year-old boy, clinicians report.
  • Making health services prices available linked to lower total claims payments October 21, 2014
    Searching a health service pricing website before using the service was associated with lower payments for clinical services such as advanced imaging and laboratory tests, according to a study.
  • Detecting cancer earlier is goal of new medical imaging technology October 21, 2014
    A new medical imaging method could help physicians detect cancer and other diseases earlier than before, speeding treatment and reducing the need for invasive, time-consuming biopsies. The potentially lifesaving technique uses nanotechnology and shortwave infrared light to reveal small cancerous tumors and cardiovascular lesions deep inside the body.
  • Exploring x-ray phase tomography with synchrotron radiation October 21, 2014
    X-ray phase tomography is an imaging technique that uses penetrating X-rays to create volumetric views through "slices" or sections of soft biological tissues, such as tumors, and it offers strongly enhanced contrast compared to conventional CT scans. Yet scientists still do not know which X-ray phase tomography methods are best suited to yield opt […]
  • See-through sensors open new window into the brain October 21, 2014
    Developing invisible implantable medical sensor arrays, a team of engineers has overcome a major technological hurdle in researchers’ efforts to understand the brain. The team has now described its technology, which has applications in fields ranging from neuroscience to cardiac care and even contact lenses.
  • See-through, one-atom-thick, carbon electrodes powerful tool to study brain disorders October 20, 2014
    A graphene, one-atom-thick microelectrode now solves a major problem for investigators looking at brain circuitry. Pinning down the details of how individual neural circuits operate in epilepsy and other brain disorders requires real-time observation of their locations, firing patterns, and other factors.
  • Pathological gambling is associated with altered opioid system in the brain October 19, 2014
    All humans have a natural opioid system in the brain. Now new research has found that the opioid system of pathological gamblers responds differently to those of normal healthy volunteers.
  • Smartphone approach for examining progression of diabetic eye disease offers comparable results to traditional method October 18, 2014
    A smartphone-based tool may be an effective alternative to traditional ophthalmic imaging equipment in evaluating and grading severity of a diabetic eye disease, according to a study. The results of the research indicate the lower-cost method could be useful for bringing the service to patients in isolated or underserved communities.

News Items

Links